Correlation Between Viridian Therapeutics and Uniper SE

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Uniper SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Uniper SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Uniper SE, you can compare the effects of market volatilities on Viridian Therapeutics and Uniper SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Uniper SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Uniper SE.

Diversification Opportunities for Viridian Therapeutics and Uniper SE

0.47

Correlation Coefficient

Viridian Therapeutics  Uniper SE

Very weak diversification

The 3 months correlation between Viridian and Uniper is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Uniper SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Uniper SE and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Uniper SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Uniper SE has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Uniper SE go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Uniper SE

Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 1.67 times more return on investment than Uniper SE. However, Viridian Therapeutics is 1.67 times more volatile than Uniper SE. It trades about 0.12 of its potential returns per unit of risk. Uniper SE is currently generating about -0.04 per unit of risk. If you would invest  1,194  in Viridian Therapeutics on September 3, 2024 and sell it today you would earn a total of  988.00  from holding Viridian Therapeutics or generate 82.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.22%
Values	Daily Returns

Viridian Therapeutics  vs.  Uniper SE

Viridian Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Viridian Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Uniper SE

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Uniper SE are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Uniper SE may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Viridian Therapeutics and Uniper SE

The main advantage of trading using opposite Viridian Therapeutics and Uniper SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Uniper SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Uniper SE will offset losses from the drop in Uniper SE's long position.

The idea behind Viridian Therapeutics and Uniper SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.